Biotech - Press Releases

Date	Title	Company
15-Jul-2020	INTELLEGENS AWARDED FUNDING BY INNOVATE UK TO MODEL COVID-19 DATA AND IMPROVE PANDEMIC MANAGEMENT	Intellegens
15-Jul-2020	APEIRON Biologics and MaxCyte Enter into Clinical and Commercial Licensing Agreement for APN401	APEIRON Biologics and MaxCyte
15-Jul-2020	BAME COMMUNITY AND CORONAVIRUS: OXFORD UNIVERSITY SPIN-OUT ZEGAMI OFFERS MEDICAL PROFESSION ITS DATA VISUALISATION SERVICES FOR FREE TO HELP FIND REASONS WHY BAME PEOPLE ARE AT GREATER RISK FROM CORONAVIRUS	Zegami
15-Jul-2020	EIT Health Wild Card winner attracts 1 million USD investment from Microsoft M12 and Mayfield	EIT Health
15-Jul-2020	Koura announces major investment into new ‘greener’ medical propellant production facility in United Kingdom	Koura
15-Jul-2020	Royal Society of Tropical Medicine and Health (RSTMH) partners with Manta Ray Media to launch grow – a new platform for greater collaboration in global health	Royal Society of Tropical Medicine and Health
15-Jul-2020	OpSec Provides a COVID-19 Authenticity & Traceability Solution for Testing Kits and Pharmaceutical Products	OpSec Security
15-Jul-2020	Onyx Health Tackles Diabetes with New Client	Onyx Health
15-Jul-2020	PureTech Founded Entity Vor Biopharma Raises $110 Million in Series B Financing	PureTech Health plc
15-Jul-2020	Major Shareholder Announcement	Genmab
15-Jul-2020	Lipidor signs agreement with CRO for implementation of Phase III clinical study of drug candidate AKP-02 against Psoriasis	Cadila Pharmaceuticals
15-Jul-2020	BAXTER ANNOUNCES PARTNERSHIP WITH ZEOSYS MEDICAL TO BRING INNOVATIVE, ENVIRONMENTALLY FRIENDLY ANAESTHESIA GAS RECAPTURE TECHNOLOGY TO HOSPITALS	Baxter Pharmaceuticals
15-Jul-2020	Enerzair® Breezhaler® (QVM149) receives regulatory approval in Europe and Japan, triggering $6.25 million in milestone payments to Vectura	Vectura
15-Jul-2020	Sosei Heptares notes Enerzair® Breezhaler® approval in the European Union as a treatment for uncontrolled asthma	Sosei Group Corporation
15-Jul-2020	Novartis receives EC approval for Enerzair® Breezhaler®, including the first digital companion (sensor and app) that can be prescribed alongside a treatment for uncontrolled asthma in the EU	Novartis
15-Jul-2020	Rates of bleeding and venous thromboembolism (VTE) events reported after 12 months of edoxaban ▼ treatment considered low by real-world ETNA-VTE study investigators	Daiichi Sankyo
15-Jul-2020	ARRAYJET SECURES $1MILLION BIO PRINTER CONTRACT WITH WORLD’S LARGEST PROTEIN MICROARRAY PRODUCER	Arrayjet
15-Jul-2020	ISPE Announces Formation of New Eurasian Economic Union Affiliate	ISPE
15-Jul-2020	Ovid Therapeutics and Angelini Pharma Enter into Exclusive License Agreement to Develop, Manufacture and Commercialize OV101 for the Treatment of Angelman Syndrome in Europe	Ovid Therapeutics
15-Jul-2020	Medicago Begins Phase I Clinical Trials for its COVID-19 Vaccine Candidate	Medicago